元大10年期以上美元投資級醫療保健債券ETF基金
基金評等 :

基金基本資料

基金類型 債券型海外債券ETF
投資區域 全球
計價幣別 台幣
基金規模(億) 5.19(2024/03/31)
經理人 陳柏彰

淨值走勢圖

基金 淨值 淨值日期 自成立日起
報酬率(%)		 自今年以來
報酬率(%)		 年化
標準差(%)		 Sharpe Beta
元大10年期以上美元投資級醫療保健債券ETF基金 34.3995 2024/05/13 5.42 0.86 10.57 0.09 1.43

績效比較圖

每年報酬率變化

區域持股分布(資料日期:2024/03/31)

產業持股分布(資料日期:2024/03/31)

主要持股(資料日期:2024/03/31)

個股名稱 比例
ABBVIE INC 4.45% 05/14/2046 0.79%
CVS HEALTH CORP 5.125% 07/20/2045 1.32%
ABBVIE INC 4.4% 11/06/2042 1.03%
AMGEN INC 5.15% 11/15/2041 0.43%
ABBOTT LABORATORIES 4.9% 11/30/2046 1.59%
AMGEN INC 4.563% 06/15/2048 0.66%
BAXALTA INC 5.25% 06/23/2045 0.75%
THERMO FISHER SCIENTIFIC 4.1% 08/15/2047 0.69%
ZOETIS INC 4.7% 02/01/2043 0.63%
CVS HEALTH CORP 5.05% 03/25/2048 2.75%
PFIZER INC 7.2% 03/15/2039 1.79%
MERCK & CO INC 3.7% 02/10/2045 0.71%
JOHNSON & JOHNSON 3.7% 03/01/2046 0.78%
GILEAD SCIENCES INC 4.75% 03/01/2046 1.19%
MEDTRONIC INC 4.625% 03/15/2045 0.87%
GILEAD SCIENCES INC 4.15% 03/01/2047 0.73%
NOVARTIS CAPITAL CORP 4.4% 05/06/2044 0.81%
PFIZER INC 4.2% 09/15/2048 0.43%
GLAXOSMITHKLINE CAP INC 6.375% 05/15/2038 1.64%
CVS HEALTH CORP 4.78% 03/25/2038 1.71%
MEDTRONIC INC 4.375% 03/15/2035 0.83%
AMGEN INC 4.663% 06/15/2051 1.33%
ABBVIE INC 4.7% 05/14/2045 1.12%
ABBOTT LABORATORIES 4.75% 11/30/2036 0.81%
ABBVIE INC 4.5% 05/14/2035 1.09%
MERCK & CO INC 4.15% 05/18/2043 0.78%
ASTRAZENECA PLC 4% 09/18/2042 0.42%
ABBVIE INC 4.875% 11/14/2048 1.08%
AMGEN INC 4.4% 05/01/2045 0.88%
WYETH LLC 5.95% 04/01/2037 1.03%
GILEAD SCIENCES INC 5.65% 12/01/2041 0.58%
BIOGEN INC 5.2% 09/15/2045 0.53%
PFIZER INC 4.4% 05/15/2044 0.52%
KAISER FOUNDATION HOSPIT 4.15% 05/01/2047 0.76%
PFIZER INC 4.125% 12/15/2046 0.48%
ELI LILLY & CO 4.15% 03/15/2059 0.63%
ASCENSION HEALTH 3.945% 11/15/2046 0.64%
GILEAD SCIENCES INC 4.5% 02/01/2045 1%
NORTHWELL HEALTHCARE INC 4.26% 11/01/2047 0.37%
JOHNSON & JOHNSON 3.55% 03/01/2036 0.66%
LABORATORY CORP OF AMER 4.7% 02/01/2045 0.28%
COMMONSPIRIT HEALTH 4.187% 10/01/2049 0.42%
BRISTOL-MYERS SQUIBB CO 5% 08/15/2045 0.54%
JOHNSON & JOHNSON 3.625% 03/03/2037 0.99%
NY & PRESBYTERIAN HOSPIT 4.024% 08/01/2045 0.54%
STRYKER CORP 4.625% 03/15/2046 0.51%
BRISTOL-MYERS SQUIBB CO 4.55% 02/20/2048 0.5%
GILEAD SCIENCES INC 4.8% 04/01/2044 0.82%
KAISER FOUNDATION HOSPIT 4.875% 04/01/2042 0.55%
COMMONSPIRIT HEALTH 4.35% 11/01/2042 0.44%
ASTRAZENECA PLC 6.45% 09/15/2037 1.61%
BOSTON SCIENTIFIC CORP 4.7% 03/01/2049 0.23%
JOHNSON & JOHNSON 4.5% 12/05/2043 0.36%
JOHNSON & JOHNSON 3.5% 01/15/2048 0.5%
MERCK & CO INC 4% 03/07/2049 0.78%
PFIZER INC 4% 03/15/2049 0.88%
NOVARTIS CAPITAL CORP 4% 11/20/2045 0.81%
ASTRAZENECA PLC 4.375% 08/17/2048 0.79%
ASTRAZENECA PLC 4.375% 11/16/2045 0.56%
NOVARTIS CAPITAL CORP 2.75% 08/14/2050 0.38%
ABBVIE INC 4.75% 03/15/2045 0.58%
PFIZER INC 2.55% 05/28/2040 0.22%
AMGEN INC 3.375% 02/21/2050 0.68%
BRISTOL-MYERS SQUIBB CO 4.25% 10/26/2049 1.4%
JOHNSON & JOHNSON 3.75% 03/03/2047 0.46%
JOHNSON & JOHNSON 2.25% 09/01/2050 0.46%
JOHNSON & JOHNSON 2.45% 09/01/2060 0.37%
AMGEN INC 3.15% 02/21/2040 0.95%
BIOGEN INC 3.15% 05/01/2050 0.46%
ELI LILLY & CO 2.25% 05/15/2050 0.23%
ELI LILLY & CO 2.5% 09/15/2060 0.22%
ABBVIE INC 4.25% 11/21/2049 1.96%
BRISTOL-MYERS SQUIBB CO 4.35% 11/15/2047 0.71%
PFIZER INC 2.7% 05/28/2050 0.8%
MERCK & CO INC 2.75% 12/10/2051 0.61%
MERCK & CO INC 2.9% 12/10/2061 1.1%
BRISTOL-MYERS SQUIBB CO 3.7% 03/15/2052 0.71%
BRISTOL-MYERS SQUIBB CO 3.9% 03/15/2062 0.52%
TAKEDA PHARMACEUTICAL 3.175% 07/09/2050 0.87%
BRISTOL-MYERS SQUIBB CO 4.125% 06/15/2039 0.61%
AMGEN INC 4.4% 02/22/2062 0.56%
JOHNS HOPKINS HEALTH SYS 3.837% 05/15/2046 0.42%
STANFORD HEALTH CARE 3.795% 11/15/2048 0.41%
MASS GENERAL BRIGHAM INC 3.342% 07/01/2060 0.26%
PFIZER INC 4.3% 06/15/2043 0.5%
ABBVIE INC 4.05% 11/21/2039 1.4%
CVS HEALTH CORP 4.875% 07/20/2035 0.36%
CVS HEALTH CORP 5.3% 12/05/2043 0.3%
JOHNSON & JOHNSON 3.4% 01/15/2038 0.59%
ABBVIE INC 4.85% 06/15/2044 0.6%
ABBOTT LABORATORIES 6.15% 11/30/2037 0.56%
COMMONSPIRIT HEALTH 3.91% 10/01/2050 0.45%
TOLEDO HOSPITAL/THE 5.75% 11/15/2038 0.44%
KAISER FOUNDATION HOSPIT 3.266% 11/01/2049 0.37%
MEMORIAL SLOAN-KETTERING 4.2% 07/01/2055 0.32%
BAPTIST HEALTHCARE 3.54% 08/15/2050 0.28%
AMGEN INC 4.2% 02/22/2052 0.41%
AMGEN INC 4.875% 03/01/2053 0.51%
GLAXOSMITHKLINE CAP INC 4.2% 03/18/2043 0.61%
BRISTOL-MYERS SQUIBB CO 3.55% 03/15/2042 0.45%
BRISTOL-MYERS SQUIBB CO 4.625% 05/15/2044 0.46%
CVS HEALTH CORP 5.625% 02/21/2053 0.49%
ELI LILLY & CO 4.875% 02/27/2053 0.85%
ELI LILLY & CO 4.95% 02/27/2063 0.48%
AMGEN INC 5.75% 03/02/2063 1.26%
AMGEN INC 5.65% 03/02/2053 2.34%
AMGEN INC 5.6% 03/02/2043 1.51%
MERCK & CO INC 5% 05/17/2053 0.98%
MERCK & CO INC 5.15% 05/17/2063 0.75%
BECTON DICKINSON & CO 4.669% 06/06/2047 0.62%
ABBVIE INC 4.55% 03/15/2035 0.84%
BECTON DICKINSON & CO 4.685% 12/15/2044 0.45%
GILEAD SCIENCES INC 4.6% 09/01/2035 0.71%
NYU LANGONE HOSPITALS 3.38% 07/01/2055 0.54%
NYU LANGONE HOSPITALS 4.368% 07/01/2047 0.11%
CVS HEALTH CORP 6% 06/01/2063 1.1%
CENCORA INC 4.3% 12/15/2047 0.27%
HACKENSACK MERIDIAN HLTH 2.875% 09/01/2050 0.21%
CENCORA INC 4.25% 03/01/2045 0.16%
CVS HEALTH CORP 5.875% 06/01/2053 0.7%
COTTAGE HEALTH SYSTEM 3.304% 11/01/2049 0.23%
NY & PRESBYTERIAN HOSPIT 3.954% 08/01/2119 0.23%
HACKENSACK MERIDIAN HLTH 2.675% 09/01/2041 0.22%
BRISTOL-MYERS SQUIBB CO 6.4% 11/15/2063 0.72%
KAISER FOUNDATION HOSPIT 3.002% 06/01/2051 0.78%
ABBOTT LABORATORIES 5.3% 05/27/2040 0.45%
ABBVIE INC 4.3% 05/14/2036 0.41%
GLAXOSMITHKLINE CAP INC 5.375% 04/15/2034 0.4%
GILEAD SCIENCES INC 5.55% 10/15/2053 0.66%
NOVARTIS CAPITAL CORP 3.7% 09/21/2042 0.31%
BRISTOL-MYERS SQUIBB CO 6.25% 11/15/2053 0.99%
THERMO FISHER SCIENTIFIC 5.404% 08/10/2043 0.38%
NOVANT HEALTH INC 3.168% 11/01/2051 0.35%
BECTON DICKINSON & CO 3.794% 05/20/2050 0.3%
BAYLOR SCOTT & WHITE HOL 2.839% 11/15/2050 0.3%
ABBOTT LABORATORIES 6% 04/01/2039 0.28%
ZOETIS INC 3.95% 09/12/2047 0.25%
BIOGEN INC 3.25% 02/15/2051 0.21%
BRISTOL-MYERS SQUIBB CO 5.55% 02/22/2054 1.34%
BRISTOL-MYERS SQUIBB CO 5.65% 02/22/2064 1.02%
ELI LILLY & CO 5.1% 02/09/2064 0.74%
ELI LILLY & CO 5% 02/09/2054 0.74%
附註：
註1: 基金績效計算皆有考慮配息，基金配息率不代表基金報酬率，且過去配息率不代表未來配息率。所有基金績效，均為過去績效，不代表未來之績效表現，亦不保證基金之最低投資收益。
註2: 基金淨值可能因市場因素而上下波動，基金淨值僅供參考，實際以基金公司公告之淨值為準；部份基金採雙軌報價，實際交易以基金公司所公告的買回價／賣出價為計算基礎。
註3: 上述銷售費用僅供參考，實際費率以各銷售機構為主。
註4: 上述短線交易規定資料僅供參考，實際規定應以基金公開說明書為主。
註5: 境內基金經行政院金融監督管理委員會核准在國內募集及銷售，惟不表示絕無風險。基金經理公司以往之經理績效不保證基金之最低投資收益；基金經理公司除盡善良管理人之注意義務外，不負責本基金之盈虧，亦不保證最低之收益，投資人申購前應詳閱基金公開說明書。
註6: 依金管會規定基金投資大陸證券市場之有價證券不得超過本基金資產淨值之10%，當該基金投資地區包含中國大陸及香港，基金淨值可能因為大陸地區之法令、政治或經濟環境改變而受不同程度之影響。
註7: 上述資料只供參考用途，嘉實資訊自當盡力提供正確訊息，但如有錯漏或疏忽，本公司或關係企業與其任何董事或任何受僱人，恕不負任何法律責任。